-
Subject Areas on Research
-
A theoretical analysis of acute ischemia and infarction using ECG reconstruction on a 2-D model of myocardium.
-
Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death.
-
Assessing the Impact of an Order Panel Utilizing Weight-Based Insulin and Standardized Monitoring of Blood Glucose for Patients With Hyperkalemia.
-
Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
-
Cause Unknown, Treatment Uncertain, Outcome Poor: An Encounter With Kidney Failure in the Developing World.
-
Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure.
-
Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists.
-
Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure.
-
Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita.
-
Diuretic complications.
-
Effect of Salt Substitution on Cardiovascular Events and Death.
-
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial.
-
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial.
-
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
-
Exchange transfusion using washed red blood cells reconstituted with fresh-frozen plasma for treatment of severe hyperkalemia in the neonate.
-
General anesthesia and hyperkalemic periodic paralysis.
-
Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality.
-
Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients.
-
Hyperkalemia in Heart Failure: Probably Not O"K".
-
Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.
-
Hyperkalemia: a review.
-
Hyperkalemia: treatment options.
-
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
-
Label-free oxygen-metabolic photoacoustic microscopy in vivo.
-
Life-threatening hyperkalemia after 2 days of ibuprofen.
-
Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy.
-
Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.
-
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.
-
Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence.
-
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
-
Potassium Disorders: Hypokalemia and Hyperkalemia.
-
Predialysis health, dialysis timing, and outcomes among older United States adults.
-
Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.
-
Renin-angiotensin system inhibition in advanced chronic kidney disease: how low can the kidney function go?
-
Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001.
-
Safety of Enalapril in Infants Admitted to the Neonatal Intensive Care Unit.
-
Succinylcholine induced hyperkalemia and cardiac arrest death related to an EEG study.
-
The electrophysiological effects of calcium channel blockade during standard hyperkalemic hypothermic cardioplegic arrest.
-
The frequency of hyperkalemia and its significance in chronic kidney disease.
-
The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.
-
The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
-
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
-
Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
-
Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.
-
Using Zero Balance Ultrafiltration with Dialysate as a Replacement Fluid for Hyperkalemia during Cardiopulmonary Bypass.
-
What's new in diuretic therapy.
-
Keywords of People